食管癌单纯放疗总的5年生存率仅5～10％。应用化疗合并放疗是否能提高疗效为广大医务工作者所关注。本院自1989年10月至今开展多种化疗方案,合并放疗(化放组),与单纯放疗组(单放组)比较,分析放化组食管癌38例与同期单放组31例作临床疗效比较,以观察食道癌放化疗的疗效及有 The total 5-year survival rate of radiotherapy for esophageal cancer is only 5 to 10%. Whether the use of chemotherapy combined with radiotherapy can improve the efficacy of medical attention for the majority of medical workers. Since October 1989, our hospital has carried out multiple chemotherapy programs, combined radiotherapy (chemotherapy group), compared with radiotherapy alone group (radiotherapy group), analyzed 38 patients with radiotherapy and esophageal cancer in radiotherapy group and 31 patients in the same period radiotherapy group for clinical Efficacy comparison to observe the efficacy of radiotherapy and chemotherapy for esophageal cancer and